BG101104A - New benzamide derivative, its preparation and use in pharmacuetical compositions - Google Patents

New benzamide derivative, its preparation and use in pharmacuetical compositions

Info

Publication number
BG101104A
BG101104A BG101104A BG10110497A BG101104A BG 101104 A BG101104 A BG 101104A BG 101104 A BG101104 A BG 101104A BG 10110497 A BG10110497 A BG 10110497A BG 101104 A BG101104 A BG 101104A
Authority
BG
Bulgaria
Prior art keywords
preparation
benzamide derivative
new benzamide
pharmacuetical compositions
pharmacuetical
Prior art date
Application number
BG101104A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Armin Fuegner
Hubert Heuer
Christopher Meade
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of BG101104A publication Critical patent/BG101104A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG101104A 1994-07-13 1997-01-04 New benzamide derivative, its preparation and use in pharmacuetical compositions BG101104A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
PCT/EP1995/002113 WO1996002496A1 (de) 1994-07-13 1995-06-03 Neue chemische verbindung, ihre herstellung und ihre verwendung als arzneistoff

Publications (1)

Publication Number Publication Date
BG101104A true BG101104A (en) 1998-04-30

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101104A BG101104A (en) 1994-07-13 1997-01-04 New benzamide derivative, its preparation and use in pharmacuetical compositions

Country Status (25)

Country Link
US (1) US5686496A (hu)
EP (1) EP0770058A1 (hu)
JP (1) JPH10502646A (hu)
KR (1) KR970704674A (hu)
CN (1) CN1152303A (hu)
AU (1) AU2736895A (hu)
BG (1) BG101104A (hu)
BR (1) BR9508395A (hu)
CA (1) CA2194886A1 (hu)
CO (1) CO4410185A1 (hu)
CZ (1) CZ8297A3 (hu)
DE (1) DE4424714A1 (hu)
EE (1) EE9700065A (hu)
FI (1) FI970095A0 (hu)
HR (1) HRP950363A2 (hu)
HU (1) HUT76827A (hu)
IL (1) IL114572A0 (hu)
MX (1) MX9700245A (hu)
NO (1) NO970123D0 (hu)
PE (1) PE35196A1 (hu)
PL (1) PL318114A1 (hu)
SK (1) SK1897A3 (hu)
WO (1) WO1996002496A1 (hu)
YU (1) YU45395A (hu)
ZA (1) ZA955781B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
EP1353661A2 (en) * 2001-01-16 2003-10-22 Boehringer Ingelheim Pharma GmbH & Co.KG Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
KR20040036908A (ko) * 2001-08-31 2004-05-03 뉴로겜 인터내셔널 리미티드 아밀로이드증 치료용 아미딘 유도체
WO2004099783A2 (en) * 2003-05-06 2004-11-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
KR100682199B1 (ko) * 2004-07-05 2007-02-12 동화약품공업주식회사 알러지성 염증 질환의 예방 및 치료용 조성물
JP3983272B2 (ja) * 2004-07-14 2007-09-26 有限会社 炎症研究所 腫瘍転移の抑制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
AU673343B2 (en) * 1992-02-05 1996-11-07 Boehringer Ingelheim International Gmbh Novel amidine derivatives, their preparation and their use as mediaments with LTB4 antagonistic effect

Also Published As

Publication number Publication date
SK1897A3 (en) 1997-08-06
MX9700245A (es) 1997-05-31
ZA955781B (en) 1996-02-22
CZ8297A3 (en) 1997-09-17
PE35196A1 (es) 1996-09-05
FI970095A (fi) 1997-01-10
HUT76827A (en) 1997-11-28
BR9508395A (pt) 1997-12-23
EE9700065A (et) 1997-08-15
EP0770058A1 (de) 1997-05-02
WO1996002496A1 (de) 1996-02-01
NO970123L (no) 1997-01-10
AU2736895A (en) 1996-02-16
HRP950363A2 (en) 1997-08-31
DE4424714A1 (de) 1996-01-18
CN1152303A (zh) 1997-06-18
HU9700060D0 (en) 1997-02-28
KR970704674A (ko) 1997-09-06
YU45395A (sh) 1997-12-05
JPH10502646A (ja) 1998-03-10
IL114572A0 (en) 1995-11-27
FI970095A0 (fi) 1997-01-10
CO4410185A1 (es) 1997-01-09
US5686496A (en) 1997-11-11
NO970123D0 (no) 1997-01-10
PL318114A1 (en) 1997-05-12
CA2194886A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
BG101104A (en) New benzamide derivative, its preparation and use in pharmacuetical compositions
GB2256138B (en) Topical terbinafine compositions
IS1812B (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
CA2134977A1 (en) Coolant Compositions
AU2002213975A1 (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
AU3776695A (en) Chair with adjustable legs
IL136503A0 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
IL150219A0 (en) Mulch composition and methods for the preparation and use thereof
IL113657A0 (en) Pharmaceutical composition based on guar gum
EP1167354A3 (en) Racemic huperzine A
GB2289472B (en) CRT adhesive composition and CRT obtained by the use thereof
HU9602798D0 (en) Benzamide derivative, compositions containing said derivative and use thereof
IL126109A0 (en) Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
HUP0003478A3 (en) Synergistic fungicidal compositions, their use and process for their preparation
IL115029A0 (en) 2,3-bridged 1,4-dihydropyridines their preparation and use
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
IL109438A0 (en) 3-Quinolyl-substituted dihydropyridines, processes for their preparation and their use in pharmaceutical compositions
GB9420616D0 (en) Method, compositions and use
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
SG59910A1 (en) Rare earth oxysulphide composition a process for the preparation thereof and use thereof as a luninophore
AU3543797A (en) 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations
AU2371895A (en) Polymer cement compositions and initiators for use in the preparation thereof
NO932823L (no) Bicyklopolyazamakrocyklofosfonsyrer, deres komplekser og konjugater, for anvendelse som kontrastmidler og fremgangsmåter for deres fremstilling